NCT07354061 2026-04-01
TD-ENSEMBLE
Tang-Du Hospital
Phase 1/2 Recruiting
Clinical Trials
3 trialsNCT04837716 2026-02-19
Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT03420508 2026-02-05
Treating Patients With Melanoma and ALK Alterations With Ensartinib
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting